相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Gastric Cancer, Version 2.2022
Jaffer A. Ajani et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)
Lymph node ratio-based the ypTNrM staging system for gastric cancer after neoadjuvant therapy: a large population-based study
Jia-Xian Chen et al.
SURGERY TODAY (2022)
High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma
Gerd Jomrich et al.
ANNALS OF SURGERY (2021)
Concurrent lymphovascular and perineural invasion after preoperative therapy for gastric adenocarcinoma is associated with decreased survival
Alisa N. Blumenthaler et al.
JOURNAL OF SURGICAL ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
A Novel Approach for Gastric Cancer Staging in Elderly Patients Based on the Lymph Node Ratio
Joonseon Park et al.
JOURNAL OF GASTRIC CANCER (2021)
The Prognostic Value of Lymph Node Ratio after Neoadjuvant Chemotherapy in Patients with Locally Advanced Gastric Adenocarcinoma
Kankai Zhu et al.
JOURNAL OF GASTRIC CANCER (2021)
Prognostic Value of Lymph Node Yield After Neoadjuvant Chemoradiation for Gastric Cancer
Casey J. Allen et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Modified Gastric Cancer AJCC Staging with a Classification Based on the Ratio of Regional Lymph Node Involvement: A Population-Based Cohort Study
Zeping Huang et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy
Ziyu Li et al.
GASTRIC CANCER (2020)
Impact of tumor regression grade on recurrence after preoperative chemoradiation and gastrectomy for gastric cancer
Alexander P. Stark et al.
JOURNAL OF SURGICAL ONCOLOGY (2020)
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Salah-Eddin Al-Batran et al.
LANCET (2019)
Post-therapy pathologic tumor volume predicts survival in gastric cancer patients who underwent neoadjuvant chemotherapy and gastrectomy
Xiaolong Tang et al.
BMC CANCER (2019)
LBA41Phase III randomized study of neoadjuvant chemotherapy (CT) with docetaxel(D), oxaliplatin(O) and S-1(S) (DOS) followed by surgery and adjuvant S-1, vs surgery and adjuvant S-1, for resectable advanced gastric cancer (GC) (PRODIGY)
Y-K Kang et al.
ANNALS OF ONCOLOGY (2019)
LBA42Perioperative chemotherapy of oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: A randomized phase III trial (RESOLVE trial)
J Ji et al.
ANNALS OF ONCOLOGY (2019)
After neoadjuvant chemotherapy platelet/lymphocyte ratios negatively correlate with prognosis in gastric cancer patients
Weipeng Gong et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2018)
The value of N staging with the positive lymph node ratio, and splenectomy, for remnant gastric cancer: A multicenter retrospective study
Sang-Yong Son et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
Value of the prognostic nutritional index in advanced gastric cancer treated with preoperative chemotherapy
Jianyi Sun et al.
JOURNAL OF SURGICAL RESEARCH (2017)
A decrease in the prognostic nutritional index is associated with a worse long-term outcome in gastric cancer patients undergoing neoadjuvant chemotherapy
Kazuhiro Migita et al.
SURGERY TODAY (2017)
Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: A meta-analysis of 17 published studies
G. Tomasello et al.
EJSO (2017)
Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection. Comparison with the current TNM staging system
K. Bouliaris et al.
EJSO (2017)
Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial
T. Grenader et al.
ANNALS OF ONCOLOGY (2016)
Lymph node ratio as a novel and simple prognostic factor in advanced gastric cancer
K. Yamashita et al.
EJSO (2016)
Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial
Elizabeth C. Smyth et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Posttherapy Nodal Status, Not Graded Histologic Response, Predicts Survival after Neoadjuvant Chemotherapy for Advanced Gastric Cancer
Kazumasa Fujitani et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
D Dindo et al.
ANNALS OF SURGERY (2004)
Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy
K Becker et al.
CANCER (2003)
分享论文
